WALTHAM, Mass., Feb. 26, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following investor conferences taking place in March 2016.
- Cowen and Company 36th Annual Health Care Conference
Presentation: Monday, March 7, 2016 at 2:00 p.m. ET*
One-on-one meetings: Monday, March 7, 2016
Location: Boston, MA
- Raymond James & Associates’ 37th Annual Institutional Investors Conference
Presentation: Tuesday, March 8, 2016 at 11:00 a.m. ET*
One-on-one meetings: Tuesday, March 8, 2016
Location: Orlando, FL
- Barclays Global Healthcare Conference
Fireside chat: Wednesday, March 16, 2016 at 3:50 p.m. ET*
One-on-one meetings: Wednesday, March 16, 2016
Location: Miami, FL
*A live webcast of the presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com, and will be archived for 30 days.
AMAG Pharmaceuticals uses its expertise to develop and commercialize products that provide clear benefits and improve people’s lives. Based in Waltham, MA, AMAG has a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care. AMAG continues to work to expand the impact of these and future products for patients by delivering on its growth strategy, which includes organic growth, as well as the pursuit of products and companies that align with AMAG’s existing therapeutic areas or those that could benefit from its proven core competencies. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals Contact: Maryann Cimino Manager, Corporate Communications & External Affairs 617-498-3375
Source:AMAG Pharmaceuticals, Inc.